Clinical trial
Kilimanjaro IPTi Drug Options Trial
NCT00158574 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00158574 |
|---|---|
| Title | Kilimanjaro IPTi Drug Options Trial |
| Official title | Drug Options for Intermittent Preventive Treatment for Malaria in Infants in an Area With High Resistance to Sulfadoxine/Pyrimethamine: an Evaluation of Short and Long-acting Antimalarial Drugs |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | University of Copenhagen National Institute for Medical Research, Tanzania Kilimanjaro Christian Medical Centre, Tanzania |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | sulphadoxine-pyrimethamine, mefloquine, Chlorproguanil-dapsone, Placebo, Sulphadoxine-pryrimethamine, IPTi mefloquine, Chlorproguanil dapsone |
| Enrollment | 2,419 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: